Adil Amarsi, Joy Xu, Josh Chan, Yuan Chun Jiang, Ahmad Zobair Omar, Yasmin Meghdadi, Aashita Doshi, Alison Xie, Alyssa Wu
{"title":"Bridging gaps throughout a patient's journey with melanoma: a systematic review.","authors":"Adil Amarsi, Joy Xu, Josh Chan, Yuan Chun Jiang, Ahmad Zobair Omar, Yasmin Meghdadi, Aashita Doshi, Alison Xie, Alyssa Wu","doi":"10.1080/20450885.2025.2545169","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Melanoma is one of the most fatal skin cancers, with rising incidence and mortality worldwide. From diagnosis to treatment, patient experiences often involve anxiety, symptom burden, and limited access to information which profoundly impacts health outcomes.</p><p><strong>Objective: </strong>This systematic review aims to identify and analyze major barriers melanoma patients face throughout their healthcare journey.</p><p><strong>Methods: </strong>Studies were identified from PubMed, Scopus, Web of Science, Embase, and Cochrane Library, supplemented by manual hand-searching. Eligible studies focused on the experiences of melanoma patients, addressed knowledge gaps and barriers to care throughout the patient journey, and were published in English between 2013 and 2023. Screening and extraction were conducted independently and in duplicate. The methodological quality of the included studies was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria.</p><p><strong>Results: </strong>Out of 2,257 screened articles, 183 met the inclusion criteria. Studies were categorized into four major themes: intersectionality, treatment, diagnosis/prognosis, and patient/societal burden. Commonly explored subcategories included self-examination, risk factors, and drug efficacy.</p><p><strong>Conclusions: </strong>Melanoma patients experience significant gaps throughout their healthcare journey. Identifying areas of improvement in current practices is the first step toward developing targeted solutions that improve the patient experience and quality of life.</p>","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":"12 1","pages":"2545169"},"PeriodicalIF":0.7000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Melanoma Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20450885.2025.2545169","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/7 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Melanoma is one of the most fatal skin cancers, with rising incidence and mortality worldwide. From diagnosis to treatment, patient experiences often involve anxiety, symptom burden, and limited access to information which profoundly impacts health outcomes.
Objective: This systematic review aims to identify and analyze major barriers melanoma patients face throughout their healthcare journey.
Methods: Studies were identified from PubMed, Scopus, Web of Science, Embase, and Cochrane Library, supplemented by manual hand-searching. Eligible studies focused on the experiences of melanoma patients, addressed knowledge gaps and barriers to care throughout the patient journey, and were published in English between 2013 and 2023. Screening and extraction were conducted independently and in duplicate. The methodological quality of the included studies was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria.
Results: Out of 2,257 screened articles, 183 met the inclusion criteria. Studies were categorized into four major themes: intersectionality, treatment, diagnosis/prognosis, and patient/societal burden. Commonly explored subcategories included self-examination, risk factors, and drug efficacy.
Conclusions: Melanoma patients experience significant gaps throughout their healthcare journey. Identifying areas of improvement in current practices is the first step toward developing targeted solutions that improve the patient experience and quality of life.
背景：黑色素瘤是最致命的皮肤癌之一，在世界范围内发病率和死亡率都在上升。从诊断到治疗，患者的经历往往涉及焦虑、症状负担和获取信息的有限，这对健康结果产生了深远的影响。目的：本系统综述旨在识别和分析黑色素瘤患者在整个医疗保健过程中面临的主要障碍。方法：从PubMed、Scopus、Web of Science、Embase和Cochrane Library中检索研究，辅以人工检索。符合条件的研究集中于黑色素瘤患者的经历，解决了患者在整个治疗过程中的知识差距和护理障碍，并在2013年至2023年期间以英文发表。筛选和提取独立进行，一式两份。纳入研究的方法学质量采用分级建议评估、发展和评价（GRADE）标准进行评估。结果：在筛选的2257篇文章中，183篇符合纳入标准。研究分为四个主要主题：交叉性、治疗、诊断/预后和患者/社会负担。通常探讨的子类别包括自我检查、危险因素和药物疗效。结论：黑色素瘤患者在整个医疗保健过程中经历了显著的差距。确定当前实践中需要改进的领域是制定有针对性的解决方案的第一步，这些解决方案可以改善患者的体验和生活质量。
期刊介绍：
Skin cancer is on the rise. According to the World Health Organization, 132,000 melanoma skin cancers occur globally each year. While early-stage melanoma is usually relatively easy to treat, once disease spreads prognosis worsens considerably. Therefore, research into combating advanced-stage melanoma is a high priority. New and emerging therapies, such as monoclonal antibodies, B-RAF and KIT inhibitors, antiangiogenic agents and novel chemotherapy approaches hold promise for prolonging survival, but the search for a cure is ongoing. Melanoma Management publishes high-quality peer-reviewed articles on all aspects of melanoma, from prevention to diagnosis and from treatment of early-stage disease to late-stage melanoma and metastasis. The journal presents the latest research findings in melanoma research and treatment, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. Key topics covered include: Risk factors, prevention and sun safety education Diagnosis, staging and grading Surgical excision of melanoma lesions Sentinel lymph node biopsy Biological therapies, including immunotherapy and vaccination Novel chemotherapy options Treatment of metastasis Prevention of recurrence Patient care and quality of life.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
